17 results on '"Jian Cao"'
Search Results
2. Protein tyrosine phosphatase receptor type R (PTPRR) antagonizes the Wnt signaling pathway in ovarian cancer by dephosphorylating and inactivating β-catenin.
- Author
-
Yuetong Wang, Jian Cao, Weiwei Liu, Jiali Zhang, Zuo Wang, Yiqun Zhang, Linjun Hou, Shengmiao Chen, Piliang Hao, Liye Zhang, Min Zhuang, Yang Yu, Dake Li, and Gaofeng Fan
- Subjects
- *
PROTEIN-tyrosine phosphatase , *PHOSPHOPROTEIN phosphatases , *OVARIAN cancer , *CATENINS , *WNT signal transduction , *CANCER cell growth - Abstract
Despite a lack of mutations, accumulating evidence supports an important role for the Wnt/β-catenin pathway in ovarian tumorigenesis. However, the molecular mechanism that contributes to the aberrant activation of the Wnt signaling cascade in ovarian cancer has not been fully elucidated. Here, we found that protein tyrosine phosphatase receptor type R (PTPRR) suppressed the activation of the Wnt/β-catenin pathway in ovarian cancer. We performed an shRNA-based biochemical screen, which identified PTPRR as being responsible for tyrosine dephosphorylation of β-catenin on Tyr-142, a key site controlling the transcriptional activity of β-catenin. Of note, PTPRR was down-regulated in ovarian cancers, and ectopic PTPRR re-expression delayed ovarian cancer cell growth both in vitro and in vivo. Using a proximity-based tagging system and RNA-Seq analysis, we identified a signaling nexus that includes PTPRR, -catenin, β-catenin, E-cadherin, and AT-rich interaction domain 3C (ARID3C) in ovarian cancer. Immunohistochemistry staining of human samples further suggested that PTPRR expression is inversely correlated with disease prognosis. Collectively, our findings indicate that PTPRR functions as a tumor suppressor in ovarian cancer by dephosphorylating and inactivating β-catenin. These results suggest that PTPRR expression might have utility as a prognostic marker for predicting overall survival. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
3. Dual-modular molecular imaging to trace transplanted bone mesenchymal stromal cells in an acute myocardial infarction model.
- Author
-
JIAN CAO, XIAO LI, NING CHANG, YINING WANG, JING LEI, ZHENGYU JIN, DACHUN ZHAO, and KAI GAO
- Subjects
- *
STROMAL cells , *MYOCARDIAL infarction , *MAGNETIC resonance imaging , *MACROPHAGES , *CELL morphology - Abstract
Background aims. The purpose of the study was to investigate the feasibility of in vitro and in vivo bioluminescence imaging (BLI), fluorescence imaging (FI) and magnetic resonance imaging (MRI) to trace transplanted bone mesenchymal stromal cells (BMSCs) labeled with the firefly luciferase (Flue) reporter gene, Cyl dyes and ultra-small super-paramagnetic iron oxide (USPIO) particles. Methods. Fluc-transfected BMSCs were further labeled with Cyl dyes and USPIO particles, respectively. Acute myocardial infarction models of different weighted Sprague-Dawley rats and Balb/c mice were established, and BLI and FI were performed in vivo and ex vivo to determine the optimal method of optical imaging. Finally, BLI and MRI were selected to trace transplanted BMSCs in a murine model in vivo. Results. BLI was found to be the optimal optical imaging method in vivo, compared with FI, and mice were found to be the optimal animal model, compared with rats. A significant BLI signal intensity was detected in the heart region in the BMSC-treated mice group (40,552 ± 6073 counts, n = 26) and gradually decreased below the detection threshold. Two distinct hypo-intense regions were observed in the anterior wall of the heart, where stem cells were injected on MR images obtained with the gradient recalled echo cine sequence in the BMSC-treated mice group. Conclusions. Transplanted BMSCs labeled with Flue reporter gene and USPIO particles can be traced with the use of BLI and MRI in a mouse model of acute myocardial infarction. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
4. Histone Demethylase Jumonji AT-rich Interactive Domain 1B (JARID1B) Controls Mammary Gland Development by Regulating Key Developmental and Lineage Specification Genes.
- Author
-
Ran Zou, Mike, Jian Cao, Zongzhi Liu, Sung Jin Huh, Polyak, Kornelia, and Qin Yan
- Subjects
- *
HISTONE demethylases , *GENETIC regulation , *MAMMARY glands , *BREAST cancer treatment , *OXIDOREDUCTASES - Abstract
The JmjC domain-containing H3K4 histone demethylase jumonji AT-rich interactive domain 1B (JARID1B) (also known as KDM5B and PLU1) is overexpressed in breast cancer and is a potential target for breast cancer treatment. To investigate the in vivo function of JARID1B, we developed Jarid1b-/- mice and characterized their phenotypes in detail. Unlike previously reported Jarid1b-/- strains, the majority of these Jarid1b-/- mice were viable beyond embryonic and neonatal stages. This allowed us to further examine phenotypes associated with the loss of JARID1B in pubertal development and pregnancy. These Jarid1b-/- mice exhibited decreased body weight, premature mortality, decreased female fertility, and delayed mammary gland development. Related to these phenotypes, JARID1B loss decreased serum estrogen level and reduced mammary epithelial cell proliferation in early puberty. In mammary epithelial cells, JARID1B loss diminished the expression of key regulators for mammary morphogenesis and luminal lineage specification, including FOXA1 and estrogen receptor α. Mechanistically, JARID1B was required for GATA3 recruitment to the Foxa1 promoter to activate Foxa1 expression. These results indicate that JARID1B positively regulates mammary ductal development through both extrinsic and cell-autonomous mechanisms. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
5. Identification of Small Molecule Inhibitors of Jumonji AT-rich Interactive Domain 1B (JARID1B) Histone Demethylase by a Sensitive High Throughput Screen.
- Author
-
Sayegh, Joyce, Jian Cao, Mike Ran Zou, Morales, Alfonso, Blair, Lauren P., Norcia, Michael, Hoyer, Denton, Tackett, Alan J., Merkel, Jane S., and Qin Yan
- Subjects
- *
HISTONE demethylases , *CANCER treatment , *BREAST cancer , *NEUROENDOCRINE tumors , *POLYPHENOLS , *LYSINE - Abstract
JARID1B (also known as KDM5B or PLU1) is a member of the JARID1 family of histone lysine demethylases responsible for the demethylation of trimethylated lysine 27 in histone H3 (H3K4me3), a mark for actively transcribed genes. JARID1B is overexpressed in several cancers, including breast cancer, prostate cancer, and lung cancer. In addition, JARID1B is required for mammary tumor formation in syngeneic or xenograft mouse models. JARID1B-expressing melanoma cells are associated with increased self-renewal character. Therefore, JARID1B represents an attractive target for cancer therapy. Here we characterized JARID1B using a homogeneous luminescence-based demethylase assay. We then conducted a high throughput screen of over 15,000 small molecules to identify inhibitors of JARID1B. From this screen, we identified several known JmjC histone demethylase inhibitors, including 2,4-pyridinedicarboxylic acid and catechols. More importantly, we identified several novel inhibitors, including 2-4(4-methylphenyl)-1,2-benzisothiazol-3(2H)-one (PBIT), which inhibits JARID1B with an IC50 of about 3 μM in vitro. Consistent with this, PBIT treatment inhibited removal of H3K4me3 by JARID1B in cells. Furthermore, this compound inhibited proliferation of cells expressing higher levels of JARID1B. These results suggest that this novel small molecule inhibitor is a lead compound that can be further optimized for cancer therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
6. Sensor Placement Strategy in Bearing-Only Passive Location System.
- Author
-
Jie, Liang, Xiao-fang, Xie, Jian, Cao, and Long-jie, Zhang
- Subjects
WIRELESS communications ,WATER consumption ,ENERGY security ,GOVERNMENT policy ,REMOTE sensing ,PUBLIC buildings - Abstract
Abstract: Through analysis and evaluation of water consumption on-site survey of near 200 large public buildings, the necessity of the application and discussion of internet of things on wireless remote transmission of water consumption data and subentry measure are discussed. This paper advances the program of wireless remote monitoring system based on internet of things, which not only provides the ways to obtain data foundation for government policy decision by internet of things on wireless remote transmission, but finds the method and potential for energy-saving. At the same time, it can implement the development of internet of things and come up to the aim of energy-saving based on internet of things. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
7. An Integrative Decision-making Model for the Operation of Sustainable Supply Chain in China.
- Author
-
Jian, Cao, Xuhong, Ye, Yu, Qi, and Yiner, Luo
- Subjects
SUPPLY chains ,DECISION making ,SUSTAINABLE development ,BUSINESS enterprises ,ENVIRONMENTAL regulations ,SENSITIVITY analysis - Abstract
Abstract: In China nowadays, some enterprises begin to develop the sustainable supply chain (S-SC) because of the strengthening of environment regulations. How to deal with certain multi-criteria decision-making problems effectively and efficiently is the key for the development of S-SC. In this paper, the main factors and their relationship during the operation of S-SC were analyzed, and combined with the analytic network approach, an integrative decision-making model was proposed to handle different kinds of decision-making problems. The decision-making process combined with a simple example was also given to describe the application of the proposed model. The conclusions are helpful to guide the construction and operation of S-SC by decision-makers. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
8. Membrane Type 1 Matrix Metalloproteinase Induces Epithelial-to-Mesenchymal Transition in Prostate Cancer.
- Author
-
Jian Cao, Chiarelli, Christian, Richman, Omer, Zarrabi, Kevin, Kozarekar, Pallavi, and Zucker, Stanley
- Subjects
- *
METALLOPROTEINASES , *PROSTATE cancer , *DNA microarrays , *CELLULAR control mechanisms , *BIOCHEMISTRY - Abstract
By mining DNA microarray data bases at GenBank™, we identified up-regulation of membrane type 1 matrix metalloproteinase (MT1-MMP) in human primary and metastatic prostate cancer specimens as compared with nonmalignant prostate tissues. To explore the role of up-regulated MT1-MMP in early stage cancer progression, we have employed a three-dimensional cell culture model. Minimally invasive human prostate cancer cells (LNCaP) were transfected with Mu-green fluorescent protein (GFP) chimeric cDNA as compared with GFP cDNA, and morphologic and phenotypic changes were characterized. GFP-expressing LNCaP cells formed multicellular spheroids with cuboidal-like epithelial morphology, whereas MT1-GFP-expressing cells displayed a fibroblast-like morphology and a scattered growth pattern in type I collagen gels. Cell morphologic changes were accompanied by decreased epithelial markers and enhanced mesenchymal markers, consistent with epithelial-to-mesenchymal transition. MT1-MMP-induced morphologic change and cell scattering were abrogated by target inhibition of either the catalytic domain or the hemopexin domain. We further demonstrated that MT1-MMP-induced phenotypic changes were dependent upon up-regulation of Wnt5a, which has been implicated in epithelial-to-mesenchymal transition. We conclude that MT1-MMP plays an important role in early cancer dissemination by converting epithelial cells to migratory mesenchymal-like cells. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
9. Furin Directly Cleaves proMMP-2 in the trans-Golgi Network Resulting in a Nonfunctioning Proteinase.
- Author
-
Jian Cao, Rehemtulla, Alnawaz, Pavlaki, Maria, Kozarekar, Pallavi, and Chiarelli, Christian
- Subjects
- *
GOLGI apparatus , *CARCINOGENESIS , *PROTEINASES , *AMINO acids , *METALLOPROTEINASES , *BIOCHEMISTRY - Abstract
Proprotein convertases play an important role in tumorigenesis and invasiveness. Here, we report that a dibasic amino acid convertase, furin, directly cleaves proMMP-2 within the trans-Golgi network leading to an inactive form of matrix metalloproteinase-2 (MMP-2). Co-transfection of COS-1 cells with both proMMP-2 and furin cDNAs resulted in the cleavage of the N-terminal propeptide of proMMP-2. The molecular mass of cleaved MMP-2 (63 kDa), detected in both cell lysates and conditioned medium, is between the intermediate and fully activated forms of MMP-2 induced by membrane type 1-MMP. Furin-cleaved MMP-2 does not possess proteolytic activity as examined in a cell-free assay. Treatment of transfected cells with a furin inhibitor resulted in a dose-dependent inhibition of proMMP-2 cleavage; recombinant tissue inhibitor of metalloproteinase-2, which binds to the active site of membrane type 1-MMP, had no inhibitory effect. Site-directed mutagenesis of amino acids in the furin consensus recognition motif of proMMP-2(R69KPR72 ↓) prevented propeptide cleavage, thereby identifying the scissile bond and characterizing the basic amino acids required for cleavage. Other experimental observations were consistent with intracellular furin cleavage of proMMP-2 in the trans-Golgi network. The furin cleavage site in other proMMPs was examined. MMP-3, which contains the RXXR furin consensus sequence, was cleaved in furin co-transfected cells, whereas MMP-1, which lacks an RXXR consensus sequence, was not cleaved. In conclusion, we report the novel observation that furin can directly cleave the RXXR amino acid sequence in the propeptide domain of proMMP-2 leading to inactivation of the enzyme. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
10. Distinct Roles for the Catalytic and Hemopexin Domains of Membrane Type 1-Matrix Metalloproteinase in Substrate Degradation and Cell Migration.
- Author
-
Jian Cao, Kozarekar, Pallavi, Pavlaki, Maria, Chiarelli, Christian, Bahout, Wadie F., and Zucker, Stanley
- Subjects
- *
METALLOPROTEINASES , *PROTEINASES , *METALLOENZYMES , *METASTASIS , *CANCER , *TUMORS - Abstract
Substrate degradation and cell migration are key steps in cancer metastasis. Membrane-type 1-matrix metalloproteinase (MT1-MMP) has been linked with these processes. Using the fluorescein isothiocyanate (FITC)-labeled fibronectin degradation assay combined with the phagokinetic cell migration assay, structure. function relationships of MT1-MMP were studied. Our data indicate that MT1-MMP initiates substrate degradation and enhances cell migration; cell migration occurs as a concurrent but independent event. Using recombinant DNA approaches, we demonstrated that the hemopexin-like domain and a nonenzymatic component of the catalytic domain of MT1-MMP are essential for MT1-MMP-mediated cell migration. Because the cytoplasmic domain of MT1-MMP was not required for MT1MMP-mediated fibronectin degradation and cell migration, it is proposed that cross-talk between the hemopexin domain of MT1-MMP and adjacent cell surface molecules is responsible for outside-in signaling. Employing cDNAs encoding dominant negative mutations, we demonstrated that Rac1 participates in the MT1-MMP signal transduction pathway. These data demonstrated that each domain of MT1-MMP plays a distinct role in substrate degradation and cell migration. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
11. Rapid Trafficking of Membrane Type 1-Matrix Metalloproteinase to the Cell Surface Regulates Progelatinase A Activation.
- Author
-
Zucker, Stanley, Hymowitz, Michelle, Conner, Cathleen E., Diyanni, Elizabeth A., and Jian Cao
- Published
- 2002
- Full Text
- View/download PDF
12. Necrosis Induction in Glioblastoma Cells Reveals a New "Bioswitch" Function for the MT1-MMP/G6PT Signaling Axis in proMMP-2 Activation versus Cell Death Decision.
- Author
-
Belkaid, Anissa, Fortier, Simon, Jian Cao, and Annabi, Borhane
- Subjects
- *
CYTOSKELETON , *ENDOPLASMIC reticulum , *CELL death , *CANCER cells , *GENE expression , *PHOSPHORYLATION - Abstract
Cytoskeleton disorganization is an early step in the activation process of matrix metalloproteinase 2 (MMP-2) by membrane type 1 MMP (MT1-MMP) but is also associated with endoplasmic reticulum (ER) dysfunction and subsequent cell death. Given evidence that the ER-embedded glucose-6-phosphate transporter (G6PT) regulates glioblastoma cell survival and that MT1-MMP is a key enzyme in the cancer cell invasive phenotype, we explored the molecular link between G6PT and MT1-MMP. Cytoskeleton-disrupting agents such as concanavalin A (ConA) and cytochalasin D triggered proMMP-2 activation and cell death in U87 glioma cells. ConA decreased G6PT gene expression, an event that was also observed in cells overexpressing the full-length recombinant MT1-MMP protein. Overexpression of a membrane-bound catalytically active but cytoplasmic domain-deleted MT1-MMP was unable to downregulate G6PT gene expression or to trigger necrosis. Gene silencing of MT1-MMP with small interfering RNA prevented proMMP-2 activation and induced G6PT gene expression. ConA inhibited Akt phosphorylation, whereas overexpression of recombinant G6PT rescued the cells from ConA-induced proMMP-2 activation and increased Akt phosphorylation. Altogether, new functions of MT1-MMP in cell death signaling may be linked to those of G6PT. Our study indicates a molecular signaling axis regulating the invasive phenotype of brain tumor cells and highlights a new "bioswitch" function for G6PT in cell survival. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
13. Feature-based collaborative design
- Author
-
Huifen, Wang, Youliang, Zhang, Jian, Cao, Lee, Sik-Fun, and Kwong, Wing-Cheong
- Subjects
- *
COMPUTER interfaces , *PRODUCT design , *MULTIUSER computer systems - Abstract
With the appearance of the concept of virtual enterprise, it is necessary to develop a system that can support the collaborative work of multi-disciplinary groups distributed in different places. This paper puts forward a feature-based collaborative design system; briefly presents a model of collaborative design and the definition, classification and relationship of the features in this system; discusses key techniques related to realizing feature-based collaborative design in detail; and finally gives the architecture of the feature-based collaborative design system. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
14. Hg1, Novel Peptide Inhibitor Specific for Kv1.3 Channels from First Scorpion Kunitz-type Potassium Channel Toxin Family.
- Author
-
Zong-Yun Chen, You-Tian Hu, Wei-Shan Yang, Ya-Wen He, Jing Feng, Bin Wang, Rui-Ming Zhao, Jiu-Ping Ding, Zhi-Jian Cao, Wen-Xin Li, and Ying-Liang Wu
- Subjects
- *
MERCURY , *POTASSIUM channels , *AUTOIMMUNE diseases , *ELECTROPHYSIOLOGY , *SCORPION venom , *PHYSIOLOGY - Abstract
The potassium channel Kv1.3 is an attractive pharmacological target for autoimmune diseases. Specific peptide inhibitors are key prospects for diagnosing and treating these diseases. Here, we identified the first scorpion Kunitz-type potassium channel toxin family with three groups and seven members. In addition to their function as trypsin inhibitors with dissociation constants of 140 nM for recombinant LmKTT-1a, 160 nM for LmKTT-1b, 124 nM for LmKTT-1c, 136 nM for BmKTT-1, 420 nM for BmKTT-2, 760 nM for BmKTT-3, and 107 nM for Hg1, all seven recombinant scorpion Kunitz-type toxins could block the Kv1.3 channel. Electrophysiological experiments showed that six of seven scorpion toxins inhibited ∼50-80% of Kv1.3 channel currents at a concentration of 1μM. The exception was rBm- KTT-3, which had weak activity. The IC50 values of rBmKTT-1, rBmKTT-2, and rHg1 for Kv1.3 channels were ∼129.7, 371.3, and 6.2 nM, respectively. Further pharmacological experiments indicated that rHg1 was a highly selective Kv1.3 channel inhibitor with weak affinity for other potassium channels. Different from classical Kunitz-type potassium channel toxins with N-terminal regions as the channel-interacting interfaces, the channel- interacting interface of Hg1 was in the C-terminal region. In conclusion, these findings describe the first scorpion Kunitztype potassium channel toxin family, of which a novel inhibitor, Hg1, is specific for Kv1.3 channels. Their structural and functional diversity strongly suggest that Kunitz-type toxins are a new source to screen and design potential peptides for diagnosing and treating Kv1.3-mediated autoimmune diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
15. Role of Matrix Metalloproteinase-9 Dimers in Cell Migration DESIGN OF INHIBITORY PEPTIDES.
- Author
-
Dufour, Antoine, Zucker, Stanley, Sampson, Nicole S., Kuscu, Cem, and Jian Cao
- Subjects
- *
METALLOPROTEINASES , *CELL migration , *PEPTIDES , *GENETIC mutation , *PROTEIN-tyrosine kinase inhibitors - Abstract
Non-proteolytic activities of matrix metalloproteinases (MMPs) have recently been shown to impact cell migration, but the precise mechanism remains to be understood. We previously demonstrated that the hemopexin (PEX) domain of MMP-9 is a prerequisite for enhanced cell migration. Using a biochemical approach, we now report that dimerization of MMP-9 through the PEX domain appears necessary for MMP-9-enhanced cell migration. Following a series of substitution mutations within the MMP-9 PEX domain, blade IV was shown to be critical for homodimerization, whereas blade I was required for heterodimerization with CD44. Blade I and IV mutants showed diminished enhancement of cell migration compared with wild type MMP-9-transfected cells. Peptides mimicking motifs in the outermost strands of the first and fourth blades of the MMP-9 PEX domain were designed. These peptides efficiently blocked MMP-9 dimer formation and inhibited motility of COS-1 cells overexpressing MMP-9, HT-1080, and MDA-MB-435 cells. Using a shRNA approach, CD44 was found to be a critical molecule in MMP-9-mediated cell migration. Furthermore, an axis involving a MMP-9-CD44-EGFR signaling pathway in cell migration was identified using antibody array and specific receptor tyrosine kinase inhibitors. In conclusion, we dissected the mechanism of pro-MMP-9-enhanced cell migration and developed structure-based inhibitory peptides targeting MMP-9-mediated cell migration. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
16. Structural Basis of a Potent Peptide Inhibitor Designed for Kv1 .3 Channel, a Therapeutic Target of Autoimmune Disease.
- Author
-
Song Han, Hong Yi, Shi-Jin Yin, Zong-Yun Chen, Hui Liu, Zhi-Jian Cao, Ying-Liang Wu, and Wen-Xin Li
- Subjects
- *
AUTOIMMUNE diseases , *AUTOIMMUNE disease treatment , *IMMUNOLOGIC diseases , *POTASSIUM channels , *IMMUNOREGULATION , *T cells - Abstract
The potassium channel Kv1.3 is an attractive pharmacological target for immunomodulation of T cell-mediated autoimmune diseases. Potent and selective blockers of Kv1.3 are potential therapeutics for treating these diseases. Here we describe the design of a new peptide inhibitor that is potent and selective for Kv1.3. Three residues (Gly11 Ile28, and Asp33) of a scorpion toxin BmKTX were substituted by Arg11, Thr28, and His33, resulting in a new peptide, named ADWX-1. The ADWX-1 peptide blocked Kv 1.3 with picomolar affinity (IC50, 1.89 pM), showing a 100-fold increase in activity compared with the native BmKTX toxin. The ADWX-1 also displayed good selectivity on Kv1.3 over related Kv1.1 and Kv1.2 channels. Furthermore, alanine-scanning mutagenesis was carried out to map the functional residues of ADWX-1 in blocking Kv1.3. Moreover, computational simulation was used to build a structural model of the ADWX-1-Kv1.3 complex. This model suggests that all mutated residues are favorable for both the high potency and selectivity of ADWX-1 toward Kv1.3. While Arg11 of ADWX-1 interacts with Asp386 in Kv1.3, Thr28 and His33 of ADWX-1 locate right above the selectivity filter-S6 linker of Kv1.3. Together, our data indicate that the specific ADWX-1 peptide would be a viable lead in the therapy of T cell-mediated autoimmune diseases, and the successful design of ADWX-1 suggests that rational design based on the structural model of the peptide-channel complex should accelerate the development of diagnostic and therapeutic agents for human channelopathies. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
17. MT1 -MMP Down-regulates the Glucose 6-Phosphate Transporter Expression in Marrow Stromal Cells.
- Author
-
Currie, Jean-Christophe, Fortier, Simon, Sina, Asmaa, Galipeau, Jacques, Jian Cao, and Annabi, Borhane
- Subjects
- *
BONE marrow , *CHEMOTAXIS , *METALLOPROTEINASES , *IMMUNE system , *RECOMBINANT proteins , *EXTRACELLULAR matrix , *GENETIC regulation - Abstract
Bone marrow-derived stromal cells BMSC) are avidly recruited by experimental vascularizing tumors, which implies that they must respond to tumor-derived growth factor cues. In fact, BMSC chemotaxis and cell survival are regulated, in part, by the membrane type-1 matrix metalloproteinase (MT1-MMP), an MMP also involved in pro-MMP-2 activation and in degradation of the extracellular matrix (ECM). Given that impaired chemotaxis was recently observed in bone marrow cells isolated from a glucose 6-phosphate transporter-deficient (G6PT-/-) mouse model, we sought to investigate the potential MT1-MMP/G6PT signaling axis in BMSC. We show that MT1-MMP-mediated activation of pro-MMP-2 by concanavalin A (ConA) correlated with an increase in the sub-G 1 cell cycle phase as well as with cell necrosis, indicative of a decrease in BMSC survival. BMSC isolated from Egr-1-/- mouse or MT1-MMP gene silencing in BMSC with small interfering RNA (siMT1-MMP) antagonized both the ConA-mediated activation of pro-MMP-2 and the induction of cell necrosis. Overexpression of recombinant full-length MT1-MMP triggered necrosis and this was signaled through the cytoplasmic domain of MT1-MMP. ConA inhibited both the gene and protein expression of G6PT, while overexpression of recombinant G6PT inhibited MT1-MMP-mediated pro-MMP-2 activation but could not rescue BMSC from ConA-induced cell necrosis. Cell chemotaxis in response to the tumorigenic growth factor sphingosine 1-phosphate was significantly abrogated in siMT1-MMP BMSC and in chlorogenic acid-treated BMSC. Altogether, we provide evidence for an MT1-MMP/G6PT signaling axis that regulates BMSC survival, ECM degradation, and mobilization. This may lead to optimized clinical applications that use BMSC as a platform for the systemic delivery of therapeutic or anti-cancer recombinant proteins in vivo. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.